AFR ArticleIt?s understood Netherlands-based behemoth Qiagen is in advanced negotiations to buy Australian diagnostics company Cellestis.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025